Drug Profile
Research programme: dual histamine H1 and H4 receptor antagonist - Griffin Discoveries
Alternative Names: H1R/H4R best-in-class - Griffin DiscoveriesLatest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Griffin Discoveries
- Class
- Mechanism of Action Histamine H1 receptor antagonists; Histamine H4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Allergic conjunctivitis; Asthma; Rhinoconjunctivitis
Highest Development Phases
- No development reported Allergic conjunctivitis; Asthma; Rhinoconjunctivitis
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Allergic-conjunctivitis in Netherlands
- 28 Aug 2020 No recent reports of development identified for research development in Asthma in Netherlands
- 28 Aug 2020 No recent reports of development identified for research development in Rhinoconjunctivitis in Netherlands